Cisplatin, a chemotherapeutic agent used in the management of several cancers, is a key component in the treatment of testicular cancer—the most common malignancy among young men. Unfortunately, the use of this drug is complicated by the development of high-frequency hearing loss, which occurs in 20% to 40% of patients with testicular cancer treated with cisplatin.
1